Dimethylamine

Dimethylamine

SCHEMBL4864584

CCOc1cccc2[nH]ccc12.CNC

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 2/20 0.58
HTR1A P08908 11/20 0.54
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53
LMNA P02545 2/20 0.53
ADRB2 P07550 2/20 0.53
ADRB1 P08588 2/20 0.53
ADRB3 P13945 2/20 0.53
DRD4 P21917 2/20 0.53
DRD3 P35462 2/20 0.53
MAPK1 P28482 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
KDM4E B2RXH2 1/20 0.53
USP2 O75604 1/20 0.53
CYP2D6 P10635 1/20 0.53
THRB P10828 1/20 0.53
CYP2C9 P11712 1/20 0.53
TSHR P16473 1/20 0.53
TP53 P04637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL827777 0.95 HTR1B (0.59) HTR1BHTR1ACYP1A2CYP3A4LMNA
SCHEMBL3799623 0.81 HTR1B (0.64) HTR1BHTR1ACYP1A2CYP3A4LMNA
SCHEMBL3798923 0.80 HTR1B (0.62) HTR1BHTR1ACYP1A2CYP3A4LMNA
SCHEMBL14893147 0.78 HTR1B (0.59) HTR1BHTR1ACYP1A2CYP3A4LMNA
SCHEMBL6481749 0.77 HTR1B (0.55) HTR1BHTR1ACYP1A2CYP3A4LMNA
SCHEMBL12720773 0.77 HTR1B (0.55) HTR1BHTR1ACYP1A2CYP3A4LMNA
SCHEMBL15252019 0.76 F9 (0.49) HTR1BHTR1ACYP1A2CYP3A4LMNA
SCHEMBL1137563 0.75 HTR1B (0.53) HTR1BHTR1ACYP1A2CYP3A4LMNA
SCHEMBL13309274 0.75 HTR1B (0.52) HTR1BHTR1ACYP1A2CYP3A4LMNA
SCHEMBL1545429 0.75 HTR1B (0.60) HTR1BHTR1ACYP1A2CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139547-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE PHARMACYCLICS, INC. (US) 2008-06-12 US disclosed
US-7368572-B2 Acetylene derivatives as inhibitors of histone deacetylase PHARMACYCLICS, INC. (US) 2008-05-06 US disclosed
EP-1656348-B1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE AXYS PHARM INC (US) 2007-02-07 EP disclosed
US-20050131018-A1 Acetylene derivatives as inhibitors of histone deacetylase AXYS PHARMACEUTICALS, INC. (US) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139547-A1 ACETYLENE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC10, HDAC2 HTR1B 3303/4885HTR1A 2805/4885CYP1A2 1980/4885
US-20050131018-A1 Acetylene derivatives as inhibitors of histone deacetylase HDAC1, HDAC10, HDAC2 HTR1B 3303/4885HTR1A 2805/4885CYP1A2 1980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.